Prognostic Impact of Postoperative Systemic Immune-Inflammation Index Changes in Epithelial Ovarian Cancer
Cancers · 24.10.2025 · 17 (21) · 3422
DOI: 10.3390/cancers17213422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.10.2025. Verfasst von Young Eun Chung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Epithelial ovarian cancer is an aggressive malignancy with poor prognosis despite advances in multimodal treatment. The systemic immune-inflammation index (SII) has emerged as a prognostic biomarker in various cancers; however, the impact of surgery-induced inflammatory changes remains unclear.
Methods
This study evaluated the prognostic significance of postoperative changes in SII among patients with epithelial ovarian cancer undergoing primary surgery. Data from 374 patients treated at Samsung Medical Center and Kangbuk Samsung Hospital between 2016 and 2021 were retrospectively reviewed. SII was calculated from complete blood counts obtained within one month before surgery and on postoperative day 1. The percentage change in SII was analyzed, and the optimal cutoff was determined using receiver operating characteristic curve analysis. Survival outcomes were assessed using Kaplan–Meier and multivariable Cox regression models.
Results
Patients with a postoperative SII increase > 98.4% (Group 2) had significantly poorer overall (HR = 1.86, p = 0.009) and progression-free survival (HR = 1.30, p = 0.112) compared with those with smaller changes (Group 1).
Discussion
High-grade histology, serous subtype, and greater intraoperative blood loss were associated with higher postoperative SII. A marked postoperative increase in SII independently predicted poor survival, suggesting that dynamic inflammatory responses rather than static baseline levels provide additional prognostic information.
Conclusions
Perioperative SII monitoring, easily obtainable from routine blood tests, may help identify high-risk patients who could benefit from intensified surveillance or adjuvant treatment. Prospective multicenter studies are warranted to validate these findings and explore whether perioperative modulation of systemic inflammation can improve outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
- Department of Obstetrics and Gynecology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
ORCID-Profile: Young Eun Chung, E Sun Paik, Seongyun Lim, Jun-Hyeong Seo, Tae-Joong Kim, Jeong-Won Lee, Yoo-Young Lee
Zitieren
APA
Chung, Y. E., Paik, E. S., Kim, M., Kim, N. H., Lim, S., Seo, J. H., Choi, C. H., Kim, T. J., Lee, J. W., & Lee, Y. Y. (2025). Prognostic Impact of Postoperative Systemic Immune-Inflammation Index Changes in Epithelial Ovarian Cancer. Cancers, 17(21), 3422. https://doi.org/10.3390/cancers17213422
Vancouver
Chung YE, Paik ES, Kim M, Kim NH, Lim S, Seo JH, et al. Prognostic Impact of Postoperative Systemic Immune-Inflammation Index Changes in Epithelial Ovarian Cancer. Cancers. 2025;17(21):3422. doi:10.3390/cancers17213422
BibTeX
@article{Chung2025,
author = {Chung, Young Eun and Paik, E Sun and Kim, Minji and Kim, Na-Hyun and Lim, Seongyun and Seo, Jun-Hyeong and Choi, Chel Hun and Kim, Tae-Joong and Lee, Jeong-Won and Lee, Yoo-Young},
title = {Prognostic Impact of Postoperative Systemic Immune-Inflammation Index Changes in Epithelial Ovarian Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {21},
pages = {3422},
doi = {10.3390/cancers17213422}
}
EUVIMED